Bernard Poussot Elected CEO of Wyeth - - BioPharm International

ADVERTISEMENT

Bernard Poussot Elected CEO of Wyeth

BioPharm Bulletin

Wyeth (Madison, NJ) has elected Bernard Poussot president and chief executive officer (CEO), effective January 1, 2008. Poussot began his career at Wyeth in 1986. In April 2006, Poussot was promoted to president and vice chairman of Wyeth, and in January 2007, he was promoted to president, chief operating officer, and vice chairman. Robert Essner, current chairman and CEO, will continue as chairman of the board of directors after his term as CEO ends at the end of 2007.

Wyeth’s release

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Novartis Reports Positive Results for Secukinumab in Ankylosing Spondylitis Trials
October 23, 2014
Pall ForteBio Releases Bioprocessing Contamination Detection Kit
October 22, 2014
Roche to Expand and Improve its Basel Site
October 22, 2014
FDA Panel Unanimously Backs Secukinumab for the Treatment of Psoriasis
October 22, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Author Guidelines
Source: BioPharm Bulletin,
Click here